Arquivamento definitivo - Art. 33 da LPI
#11.1.1
12/02/2025
RPI 2865
Application data
Number
112024004389Type
Filing
Publication
PCT
CN2022117336 The application was abandoned: examination was not requested within the 36 months following the 09/06/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/02/2025. We update with every new RPI gazette, published weekly.
Applicants
QILU ANIMAL HEALTH PRODUCTS CO., LTD.
CN
SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD.
CN
Inventors
C. C. (pessoa física)
CN
C. B. (pessoa física)
CN
S. D. (pessoa física)
CN
W. J. (pessoa física)
CN
IPC Classification
Priority claims
CN
202111044417.4 · 09/07/2021
CN
202111226591.0 · 10/21/2021
CN
202111470155.8 · 12/03/2021
CN
202111674718.5 · 12/31/2021
CN
202211031927.2 · 08/26/2022
Abstract
INIBIDOR DE 3CLPRO PROTEASE. São fornecidos um inibidor de 3Clpro protease, uma composição farmacêutica que contém o composto da fórmula (I), e um método para tratar coronavírus com uso do composto.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
12/02/2025
RPI 2865
#11.1
09/16/2025
RPI 2854
#1.3
06/18/2024
RPI 2789
#1.1
03/12/2024
RPI 2775
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.